Press release
Omics Based Clinical Trials Market Tends To Account For Over US$ 26.6 By 2031
Fact.MR offers detailed analysis on the global omics based clinical trials market with a 360-degree view for the forecast period of 2022 to 2032. It also provides key information such growth drivers, trends, and opportunities across multiple segments including phase type, study design type, indication, and application across seven major regions.The global omics-based clinical trials market is projected to expand by 2.2x, exhibiting growth at 8.1% CAGR during the forecast period. As per the study, the sales in omics based clinical trials market is projected to reach a valuation of US$ 61.7 Bn by 2032.
Download FREE Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7170
Surging need for the stratification of patients to understand complex diseases and therapeutic strategies will create substantial growth prospects for the market. Besides this, rising adoption of new technologies, methods, and models in clinical trials following the outbreak of COVID-19 will positively impact the market.
In addition to this, increasing number of oncology trials has turned the focus on the application of omics-based studies. This will propel the growth in the market over the coming years.
With growing requirement of personalized medicine and orphan drugs, the demand for omics technologies and sequencing technologies is spurring. This is expected to boost the demand for omics based clinical trials in the market.
Further, rising investments in the research & development (R&D) activities to develop precision medicine-based data by prominent players to update their product line is likely to drive the market.
Subsequently, increased application of single-cell multi-omics technology, non-invasive instruments, and traditional labs will surge the demand in the market. This is expected to bolster the growth in omics based clinical trials market.
Report Attributes Details
Base Year Value (2021A) US$ 26.2 Bn
Projected Year Value (2032F) US$ 61.7 Bn
Global Growth Rate (2022-2032) CAGR 8.1%
Key Takeaways:
• The U.S. omics based clinical trials market is expected to hold over 35% of demand share due to the growing prevalence of cancer and cardiovascular disorders.
• Based on indication, the oncology segment is estimated to register growth at 7.5% CAGR between 2022 and 2032.
• Asia Pacific omics based clinical trials market is anticipated to grow at a CAGR of nearly 9.0%.
• In terms of study design type, the interventional studies segment is expected to grow at an annual rate of 8.4% over the forecast period.
• By phase type, phase II segment is projected to dominate the market, exhibiting growth at a 7.6% CAGR through 2032.
Get Customization on this Report for Specific Research Solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=7170
Growth Drivers:
• Prevalence of chronic illnesses is increasing the demand for biological targets, such as biomarkers, serving as clinical risks and therapeutic target. This is likely to augment the growth of the market.
• Advancements in omics technologies allows detailed analysis of proteome, metabolome, genome, and transcriptome, thereby, enabling the growth in the market.
Restraints:
• Increase in expenditure during the omics based clinical trials is projected to hinder the growth in the market.
Competitive Landscape:
The market for omics based clinical trials is highly competitive due to the presence of small & medium enterprises and large enterprises. Besides this, the adoption of diverse tactics by the manufacturers is likely to aid their businesses.
Prominent companies operating in the global omics based clinical trials market are focusing on innovating their manufacturing capabilities and product lines to enhance their global footprint.
For instance,
• February 2021: Parexel entered into strategic partnership with Neo Genomics to advance their study designs and surge patient matching in oncology clinical trials.
• December 2021: Rebus Biosystems Inc., a U.S. based life science technology company, acquired EEL Transcriptomics AB's assay assets and investigational products (IP).
Key Companies Profiled by Fact.MR
• Parexel International Corporation
• Charles River Laboratory
• Pharmaceutical Product Development (PPD)
• Pfizer Inc.
• Covance Inc.
• ICON plc
• SGS SA
• Rebus Bio
• Eli Lilly and Company
Get Full Access of Complete Report: https://www.factmr.com/checkout/7170
More Valuable Insights on Omics Based Clinical Trials Market
Fact.MR, in its latest report, provides in-depth market analysis on the global omics based clinical trials market for the forecast period of 2022 to 2032. This study also offers crucial insights into the growth opportunities and key trends impacting the sales in the omics based clinical trials market
through detailed segmentation as follows:
By Phase Type:
• Phase 1
• Phase 2
• Phase 3
• Phase 4
By Study Design Type:
• Interventional Studies
• Observational Studies
• Expanded Access Studies
By Indication:
• Oncology
• Cardiology
• Respiratory Diseases
• Skin Diseases
• CNS Diseases
• Immunology
• Genetic Diseases
• Other Indications
By Region:
• North America
• Latin America
• Europe
• APAC
• MEA
Key Questions Covered in the Omics Based Clinical Market Report
• What will be the growth rate of the global omics based clinical market during 2022-2032?
• Who are the manufacturers dominating the global omics based clinical market?
• Which are the latest trends contributing to the growth of the omics based clinical market?
• What is the forecast sales of omics based clinical market in 2022?
• Which are the factors hampering the expansion of the global omics based clinical market?
• What is the estimated market share of global omics based clinical market during the forecast period (2022-2032)?
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Omics Based Clinical Trials Market Tends To Account For Over US$ 26.6 By 2031 here
News-ID: 2847026 • Views: …
More Releases from Fact.MR
Organic Rice Syrup Market is forecasted to increase at a CAGR of 5.1% and US$ 1. …
The global Organic Rice Syrup Market is projected to expand steadily over the coming decade, driven by rising consumer demand for natural, clean-label sweeteners and growing awareness of health and wellness trends. Industry analysts estimate that the organic rice syrup market, valued at approximately USD 450 million in 2025, is expected to reach nearly USD 880 million by 2035, registering a compound annual growth rate (CAGR) of about 7.1% during…
Compound Horse Feedstuff Market is Estimated to Grow at a CAGR of 4.6%, Reaching …
The global compound horse feedstuff market is galloping toward steady growth, projected to expand from a valuation of USD 3.8 billion in 2026 to approximately USD 5.4 billion by 2036. This represents a compound annual growth rate (CAGR) of 3.6% over the ten-year forecast period.
The market is being driven by the "humanization" of equine companions, the professionalization of equestrian sports, and a significant shift toward specialized performance nutrition that…
Nutritional Yeast Market Forecasted CAGR is 7.1% by 2035 | Fact.MR Report
The global nutritional yeast market is experiencing a significant surge in demand, projected to grow from a valuation of USD 515.2 million in 2026 to approximately USD 1.2 billion by 2036. This represents a robust compound annual growth rate (CAGR) of 8.8% over the ten-year forecast period.
The market is being propelled by the global explosion of plant-based diets and the "clean-label" movement, with nutritional yeast emerging as the primary…
Dairy Stabilizer Market is Expected to Reach USD 1,420.0 million by 2035 | Resea …
The global Dairy Stabilizers Market is projected to sustain solid growth over the next decade as consumer demand for high-quality dairy and dairy-based products continues to expand across foodservice and retail sectors. Industry analysts estimate that the dairy stabilizers market, valued at approximately USD 2.4 billion in 2025, is expected to reach around USD 4.3 billion by 2035, registering a compound annual growth rate (CAGR) of about 6.5% during the…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
